Journal: International Journal of Molecular Sciences
Article Title: Ticagrelor Induces Angiogenesis in Progenitor and Mature Endothelial Cells In Vitro: Investigation of the Possible Role of Adenosine
doi: 10.3390/ijms252413343
Figure Lengend Snippet: The effects of the adenosine receptor A 2A antagonist SCH58621, adenosine receptor A 2B inverse agonist, and antagonist MRS1706 on capillary-like tube formation by ( A ) ECFCs and ( B ) HUVECs, and on spheroid sprout formation by ( C ) ECFCs and ( D ) HUVECs, induced by ticagrelor, adenosine, and their combination. The values represent the means ± SDs from at least 6 independent biological replicates each performed in 2 technical replicates. * p < 0.02 and ** p < 0.01 compared to ticagrelor, adenosine, or their combination in the absence of SCH58621 and MRS1706. # p < 0.05 compared to ticagrelor, adenosine, or their combination in the presence of either SCH58621 or MRS1706. HUVECs: human umbilical vein endothelial cells, ECFCs: endothelial colony-forming cells.
Article Snippet: Adenosine, DPCPX (A 1 AR antagonist), 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine-labeled acetylated LDL (DiI-ac-LDL), and adenosine deaminase were purchased from Sigma-Aldrich (St. Louis, MO, USA), and MRS1220 (A 3 AR antagonist), SCH58621 (A 2A AR antagonist), and MRS1706 (A 2B AR inverse agonist and antagonist) were purchased from Tocris Bioscience (Bristol, UK).
Techniques: